查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2015205

病人參與解決方案市場：按組件、交付方式、最終用戶和應用分類－2026-2032年全球市場預測

Patient Engagement Solution Market by Component, Delivery Mode, End User, Application - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，病人參與解決方案市場價值將達到 198.9 億美元，到 2026 年將成長至 213 億美元，到 2032 年將達到 365.9 億美元，複合年成長率為 9.09%。

主要市場統計數據
基準年 2025 198.9億美元
預計年份：2026年 213億美元
預測年份 2032 365.9億美元
複合年成長率 (%) 9.09%

這篇權威的介紹概述了病人參與平台如何改善現代醫療保健系統中的護理連續性、營運彈性和病患體驗。

病人參與解決方案正在重塑醫療系統與病患之間的聯繫，加速從分散化醫療轉向持續性、數據驅動型醫病關係的轉變。這些解決方案提供廣泛的功能，可增強預約安排、藥物依從性、遠距醫療和個人化溝通。透過實現更及時的互動和更豐富、更按時間順序排列的數據，它們有助於改善臨床決策、提高營運效率並提升患者體驗。如今，醫療領導者不再將互動平台視為可有可無的附加功能，而是將其視為必不可少的基礎設施，並將其與電子健康記錄系統、收入週期工作流程和護理管理程序整合。

快速的技術創新、消費者層面的體驗期望以及監管重點如何重塑病人參與策略和供應商差異化。

在技​​術創新、以結果為導向的監管以及消費者對無縫數位化體驗日益成長的期望的推動下，病人參與格局正在經歷快速而結構性的變化。模組化架構和API優先平台的興起加速了與電子健康記錄和周邊系統的整合，而雲端原生技術的應用則提高了可擴展性和價值實現速度。這些技術變革降低了醫療系統拓展病患群體和臨床路徑參與能力的門檻。

本研究評估了 2025 年費用修訂對整合病人參與硬體和軟體生態系統的採購、採購策略和部署計畫的影響。

貿易夥伴在2025年實施的關稅政策變化，對支持病人參與技術的生態系統產生了顯著的下游影響，尤其對硬體組件、周邊設備和進口基礎設施而言更是如此。許多互動解決方案依賴軟硬體的混合組合，包括安全自助服務終端、現場設備、遠端監控感測器和整合式遠端醫療推車。由於這些實體組件依賴跨境供應鏈，關稅上漲和海關程序的日益複雜正在推高採購成本、延長前置作業時間，並迫使採購團隊重新評估供應商關係和庫存策略。

關鍵細分洞察揭示了元件、交付模式、最終用戶需求和應用管道如何整合，從而塑造部署和價值實現。

精細的細分方法揭示了每個功能組件、交付模式、最終用戶群和應用程式的不同部署模式和技術優先順序。從組件角度來看，諮詢、實施和支援等服務在確保永續部署方面發揮核心作用。同時，專注於預約管理、用藥提醒和遠端醫療的軟體模組構成了驅動日常患者互動的基礎營運架構。這意味著，採購者通常會評估專業服務和軟體包功能的組合，以配合其組織的準備情況和臨床醫生的工作流程。

美洲、歐洲、中東和非洲以及亞太地區的區域監管重點、基礎設施成熟度和支付方趨勢如何驅動不同的部署路徑和策略。

區域趨勢正在影響策略重點、監管考慮和部署模式，從而在全球主要市場形成不同的部署路徑。在美洲，重點在於那些既能展現營運效率，又能兼顧可擴展性、支付方參與度以及符合各州和國家隱私法規的解決方案。各機構優先考慮能夠支援在不同臨床環境中快速部署，並提供強大的分析能力以監測參與效果的夥伴關係。

關鍵供應商趨勢表明，互通性、安全性、夥伴關係和創新合約模式如何決定競爭地位和買家偏好。

主要供應商之間的競爭趨勢表明，他們在互通性、安全性和可驗證的臨床影響方面呈現出趨同的優先事項。投資於開放API和基於標準的整合方案的公司，透過簡化電子健康記錄（EHR）連接並賦能生態系統合作夥伴擴展功能，正在獲得競爭優勢。安全性和資料管治仍然是至關重要的要求。那些能夠展現嚴格的第三方審計、強大的加密措施和穩健的身份管理框架的供應商，正在贏得企業買家和注重隱私的監管機構的信任。

為領導者提供切實可行的建議，以加快採用速度、降低實施風險，並將病人參與策略與臨床和商業性優先事項保持一致。

產業領導者可以透過專注於實際可行的措施來減少摩擦、提升效果並強化商業性地位，從而加速其影響力。首先，應優先考慮模組化、可互通的架構，以實現分階段部署並與電子健康記錄 (EHR) 和周邊系統無縫整合。這可以降低部署風險，並有助於快速實現核心效益。其次，應以公平性和可及性為核心設計使用者互動路徑，確保行動端和網頁端體驗能夠在各種裝置類型、連接環境和不同的患者群體中正常運行，從而避免加劇醫療保健方面的不平等現象。

採用透明、多方面的調查方法，結合與關鍵相關人員的直接互動、二手技術分析和檢驗，確保相關性和可重複性。

支持這些發現的研究採用了一種混合方法，結合了初步的定性研究、嚴謹的次要分析和技術檢驗。初步研究包括與醫療服務體系、保險公司、解決方案供應商和實施合作夥伴等相關人員進行結構化訪談和研討會，以直接了解推廣促進因素、營運障礙和價值實現。此外，還組織了專家小組和臨床醫生圓桌會議，以檢驗工作流程假設和臨床影響路徑。

結論簡潔明了，認為互通性、包容和基於指標的參與策略對於將技術轉化為永續的臨床和營運價值至關重要。

病人參與解決方案已從新興事物發展成為必不可少的要素，構成醫療保健系統基礎設施的關鍵層，支撐著醫療服務的連續性、病患體驗和營運韌性。模組化軟體功能、雲端交付選項和行動優先應用程式的整合，使醫療機構能夠在不中斷核心臨床工作流程的情況下，實施針對性干預措施，應對預約、用藥依從性和遠距醫療等挑戰。如今，策略實施的關鍵在於選擇高度互通性且安全的解決方案，這些方案能夠帶來可衡量的結果，並可根據當地情況和法律規範進行調整。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 市場進入策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：病人參與解決方案市場：按組件分類

  • 服務
    • 諮詢
    • 執行
    • 支援
  • 軟體
    • 預約管理
    • 服藥提醒
    • 遠端醫療

第9章：病人參與解決方案市場：以交付方式分類

  • 雲
    • 私有雲端
    • 公共雲端
  • 現場
    • 客製化實施方案
    • 直接實施

第10章：病人參與解決方案市場：依最終使用者分類

  • 病人
    • 慢性疾病患者
    • 普通病人
  • 保險公司
    • 政府
    • 私人的
  • 醫療保健提供者
    • 診所
    • 醫院

第11章病人參與解決方案市場：按應用分類

  • 行動應用
    • Android
    • iOS
  • 網路入口網站
    • 患者門戶
    • 醫療保健提供者入口網站

第12章：病人參與解決方案市場：按地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第13章：病人參與解決方案市場：按群體分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章病人參與解決方案市場：按國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章：美國病人參與解決方案市場

第16章：中國病人參與解決方案市場

第17章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Allscripts Healthcare Solutions, Inc.
  • Cerner Corporation
  • Conversa Health, Inc.
  • Epic Systems Corporation
  • GetWellNetwork, Inc.
  • Koninklijke Philips NV
  • McKesson Corporation
  • Medisafe, Inc.
  • NextGen Healthcare, Inc.
  • Welltok, Inc.
Product Code: MRR-030EE485159B

The Patient Engagement Solution Market was valued at USD 19.89 billion in 2025 and is projected to grow to USD 21.30 billion in 2026, with a CAGR of 9.09%, reaching USD 36.59 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 19.89 billion
Estimated Year [2026] USD 21.30 billion
Forecast Year [2032] USD 36.59 billion
CAGR (%) 9.09%

An authoritative introduction outlining how patient engagement platforms elevate care continuity, operational resilience, and patient experience in modern health systems

Patient engagement solutions are reshaping the interface between health systems and the individuals they serve, accelerating a shift from episodic care to continuous, data-driven relationships. These solutions span a range of capabilities that enhance appointment coordination, medication adherence, remote consultation, and personalized communication. By enabling more timely interactions and richer longitudinal data, they support improved clinical decision-making, operational efficiency, and patient experience. Health leaders now view engagement platforms as critical infrastructure rather than optional adjuncts, integrating them with electronic health record systems, revenue cycle workflows, and care management programs.

Adoption momentum is rooted in both technology maturation and evolving stakeholder expectations. Advances in mobile platform usability, secure messaging, teleconferencing, and intelligent automation have reduced barriers to use for diverse patient cohorts. At the same time, payers and regulators increasingly prioritize measures tied to outcomes, access, and cost containment, creating incentives for providers to adopt engagement tools that demonstrably affect utilization and adherence. Consequently, organizations are evaluating engagement solutions through strategic lenses that combine clinical quality, digital inclusion, and long-term patient relationships, seeking partners and platforms that can scale, interoperate, and deliver measurable improvements across service lines.

How rapid technological innovation, consumer-grade experience expectations, and regulatory emphasis are reshaping patient engagement strategies and vendor differentiation

The landscape for patient engagement has experienced rapid, structural shifts driven by technological innovation, regulatory emphasis on outcomes, and heightened consumer expectations for seamless digital experiences. The rise of modular architectures and API-first platforms has enabled faster integrations with electronic health records and ancillary systems, while cloud-native deployments have improved scalability and time-to-value. These technological changes have reduced the friction for health systems seeking to deploy engagement capabilities across patient populations and clinical pathways.

Concurrently, user expectations that mirror broader consumer technology experiences are pushing developers to prioritize intuitive design, accessibility, and multi-channel interaction. The increasing acceptance of telehealth and remote monitoring is expanding the range of services considered part of the engagement stack, from appointment scheduling to medication reminders and virtual consultations. These shifts elevate interoperability, data security, and measurable outcomes as competitive differentiators for solution providers. Providers and payers are now focusing on partnerships that enable cohesive digital care journeys, operational analytics, and continuous improvement cycles driven by real-world usage data.

Assessing how tariff changes in 2025 have reshaped procurement, sourcing strategies, and deployment timelines for integrated patient engagement hardware and software ecosystems

Tariff policy changes introduced by trade partners in 2025 have had material downstream effects on the ecosystem that supports patient engagement technologies, particularly where hardware components, peripheral devices, and imported infrastructure are concerned. Many engagement solutions rely on a hybrid blend of software and hardware: secure kiosks, point-of-care devices, remote monitoring sensors, and integrated telehealth carts. Where these physical elements depend on cross-border supply chains, increased duties and customs complexity have raised procurement costs, prolonged lead times, and forced procurement teams to reassess vendor relationships and inventory strategies.

Software elements are less directly affected by tariffs, yet the overall cost structure of integrated solutions can shift when hardware becomes more expensive or scarce. Providers faced with increased capital expenditure for devices may delay rollout phases of broader engagement programs, or they may prioritize software-centric modules such as appointment management and medication reminders that have lower hardware dependencies. In response, some vendors have accelerated partnerships with domestic manufacturers, expanded sourcing options, and adapted device specifications to reduce components subject to the highest duties. Cloud and hosting strategies have also been recalibrated where data center hardware imports are implicated, and long-term procurement plans now explicitly incorporate tariff risk and supplier redundancy as key decision criteria.

The cumulative impact extends beyond procurement economics. Project managers and implementation teams now build contingency allowances into timelines and risk registers, while clinical leadership evaluates phased rollouts that maintain core engagement benefits without over-reliance on hardware shipments. Payers and contracting teams monitor cost pass-through effects and adjust contracting mechanisms to preserve value while mitigating short-term price shocks. In short, the tariff environment of 2025 has prompted a strategic reassessment across the value chain, favoring flexible, software-led engagement models and diversified supply strategies that preserve accessibility and continuity of patient services.

Key segmentation insights illuminating how components, delivery models, end user needs, and application channels converge to shape adoption and value realization

A nuanced segmentation approach reveals different adoption patterns and technology priorities across functional components, delivery modes, end user groups, and applications. When looking at components, services such as consulting, implementation, and support play a central role in ensuring sustainable deployments, while software modules focused on appointment management, medication reminders, and telehealth form the operational backbone that drives daily patient interactions. This means buyers typically evaluate a combination of professional services and packaged software capability to match organizational readiness and clinician workflows.

Delivery mode significantly influences deployment cadence and total cost of ownership considerations. Cloud offerings, whether deployed as private cloud to meet stringent data residency or security requirements or public cloud for rapid scalability and cost efficiency, appeal to organizations prioritizing agility. Conversely, on premise deployments, whether customized for tightly integrated enterprise environments or configured for direct deployment in legacy infrastructures, resonate with institutions that need control over the environment and integration pathways. End users shape requirements in meaningful ways: patients, whether managing chronic conditions or seeking general care, demand intuitive mobile and web access; payers, public or private, focus on engagement mechanisms that demonstrate improved compliance and reduced utilization; providers, including clinics and hospitals, require solutions that fit within clinical workflows and do not add administrative burden.

Application channel preferences influence design choices and development priorities. Mobile apps, delivered across Android and iOS platforms, enable real-time engagement and notifications that drive adherence and participation, while web portals, differentiated into patient portals and provider portals, serve as hubs for detailed record review, messaging, and care coordination. Effective strategies therefore merge component capability with delivery considerations, end user needs, and application channel design to produce cohesive solutions that can be tailored across lines of service and patient populations.

How regional regulatory priorities, infrastructure maturity, and payer dynamics in the Americas, Europe Middle East & Africa, and Asia-Pacific drive differentiated adoption paths and deployment strategies

Regional dynamics influence strategic priorities, regulatory considerations, and deployment models, yielding different pathways to adoption across major global markets. In the Americas, emphasis centers on scalability, payer integration, and solutions that can demonstrate operational efficiency while meeting diverse state and national privacy regulations. Organizations prioritize partnerships that can support rapid implementation across disparate clinical settings and offer robust analytics to monitor engagement outcomes.

Across Europe, Middle East & Africa, regulatory harmonization efforts, evolving reimbursement structures, and digital health initiatives drive a focus on interoperability, data protection, and inclusive design. In some markets, government-led programs and national digital health strategies accelerate adoption of telehealth and remote patient monitoring components, while providers seek solutions that can navigate complex cross-border data flows and compliance regimes.

The Asia-Pacific region presents both rapid adoption potential and heterogeneity in infrastructure maturity. Large urban centers often prioritize mobile-first engagement strategies and public cloud deployments, while emerging markets require solutions that perform reliably across variable connectivity and device capabilities. Regional strategies therefore blend scalability with localization, supporting multilingual interfaces, offline functionality, and partnerships with local system integrators to ensure sustainable adoption and cultural relevance.

Key vendor dynamics showing how interoperability, security, partnerships, and innovative contracting models determine competitive position and buyer preference

Competitive dynamics among leading vendors reveal converging priorities around interoperability, security, and demonstrable clinical impact. Companies investing in open APIs and standards-based integrations gain advantage by simplifying EHR connectivity and enabling ecosystem partners to extend functionality. Security and data governance remain table stakes: vendors that can evidence rigorous third-party audits, strong encryption practices, and robust identity management frameworks earn trust from enterprise buyers and privacy-focused regulators.

Strategic partnerships, particularly those that combine clinical expertise with software agility, accelerate solution maturity and market traction. Collaboration between technology vendors, device manufacturers, and healthcare systems fosters product roadmaps that align with clinician workflows and patient needs. Additionally, a growing number of acquisitions and minority investments aim to close gaps in capability-such as embedding advanced analytics, behavioral nudging techniques, or language localization-allowing incumbents to offer broader, more cohesive suites.

Innovation in monetization and contracting models is also notable. Vendors experimenting with outcome-aligned agreements, modular licensing, and managed services options are reducing procurement friction and demonstrating alignment with organizational risk appetites. Ultimately, companies that balance product depth with implementation support and measurable value propositions position themselves most favorably in buyer selection processes.

Actionable recommendations for leaders to accelerate adoption, reduce implementation risk, and align patient engagement strategies with clinical and commercial priorities

Industry leaders can accelerate impact by focusing on practical levers that reduce friction, enhance outcomes, and strengthen commercial positioning. First, prioritize modular, interoperable architectures that enable phased adoption and seamless integration with electronic health records and ancillary systems; this reduces implementation risk and allows rapid realization of core benefits. Second, design engagement pathways that center equity and accessibility, ensuring that mobile and web experiences work across device types, connectivity levels, and diverse patient populations to avoid widening care disparities.

Leaders should also embed measurable performance indicators into every deployment, ensuring that clinical teams and commercial stakeholders can track adherence, appointment utilization, and patient satisfaction over time. Use these metrics to iterate on workflow integrations and communication strategies. From a supply perspective, diversify sourcing and consider software-first approaches where hardware dependencies create vulnerability. Strengthen partnerships with payers and value-based programs by aligning engagement initiatives with reimbursement incentives and documented outcomes. Finally, invest in change management and clinician enablement to reduce adoption barriers: training, streamlined workflows, and administrative support are critical to sustain usage and demonstrate the long-term return on engagement investments.

A transparent blended research methodology combining primary stakeholder engagements, secondary technical analysis, and validation to ensure relevance and reproducibility

The research underpinning these insights relies on a blended methodology that combines primary qualitative engagement with rigorous secondary analysis and technical validation. Primary research included structured interviews and workshops with stakeholders across provider systems, payer organizations, solution vendors, and implementation partners to capture firsthand perspectives on adoption drivers, operational barriers, and value realization. These engagements were complemented by expert panels and clinician roundtables to validate workflow assumptions and clinical impact pathways.

Secondary analysis incorporated public regulatory guidance, vendor product documentation, academic literature on digital health outcomes, and trend analysis in adjacent technology sectors. Technical validation involved scenario testing of integration approaches, evaluation of security frameworks, and assessment of deployment models across cloud and on premise environments. Data synthesis prioritized triangulation: where multiple independent sources converged on the same finding, the insight was elevated in confidence. Limitations include the rapid evolution of software releases and regional policy updates; accordingly, readers should consider these findings as a strategic foundation to be contextualized against the latest local regulations and vendor roadmaps. The methodology emphasizes transparency, reproducibility, and stakeholder validation to ensure practical relevance to decision-makers.

A concise conclusion arguing that interoperable, inclusive, and metrics-driven engagement strategies are essential to translate technology into lasting clinical and operational value

Patient engagement solutions have moved from novelty to necessity, forming an essential layer of health system infrastructure that supports continuity of care, patient experience, and operational resilience. The convergence of modular software capabilities, cloud delivery options, and mobile-first applications has enabled organizations to implement targeted interventions that address appointment access, medication adherence, and remote consultations without disrupting core clinical workflows. Strategic adoption now hinges on selecting interoperable, secure solutions that offer measurable outcomes and can be adjusted to local conditions and regulatory frameworks.

The cumulative impacts of supply chain pressures, regulatory emphasis on value, and evolving consumer expectations will continue to shape procurement and deployment strategies. Organizations that embrace flexible architectures, diversify sourcing, and design inclusive user experiences will be best positioned to sustain engagement gains. Ultimately, success depends not only on technology selection but on the integration of clinical leadership, payer alignment, and operational change management to translate platform capabilities into sustained improvements in health outcomes and patient satisfaction.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Patient Engagement Solution Market, by Component

  • 8.1. Services
    • 8.1.1. Consulting
    • 8.1.2. Implementation
    • 8.1.3. Support
  • 8.2. Software
    • 8.2.1. Appointment Management
    • 8.2.2. Medication Reminders
    • 8.2.3. Telehealth

9. Patient Engagement Solution Market, by Delivery Mode

  • 9.1. Cloud
    • 9.1.1. Private Cloud
    • 9.1.2. Public Cloud
  • 9.2. On Premise
    • 9.2.1. Customized Deployment
    • 9.2.2. Direct Deployment

10. Patient Engagement Solution Market, by End User

  • 10.1. Patients
    • 10.1.1. Chronic Patients
    • 10.1.2. General Patients
  • 10.2. Payers
    • 10.2.1. Government
    • 10.2.2. Private
  • 10.3. Providers
    • 10.3.1. Clinics
    • 10.3.2. Hospitals

11. Patient Engagement Solution Market, by Application

  • 11.1. Mobile Apps
    • 11.1.1. Android
    • 11.1.2. iOS
  • 11.2. Web Portals
    • 11.2.1. Patient Portal
    • 11.2.2. Provider Portal

12. Patient Engagement Solution Market, by Region

  • 12.1. Americas
    • 12.1.1. North America
    • 12.1.2. Latin America
  • 12.2. Europe, Middle East & Africa
    • 12.2.1. Europe
    • 12.2.2. Middle East
    • 12.2.3. Africa
  • 12.3. Asia-Pacific

13. Patient Engagement Solution Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Patient Engagement Solution Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. United States Patient Engagement Solution Market

16. China Patient Engagement Solution Market

17. Competitive Landscape

  • 17.1. Market Concentration Analysis, 2025
    • 17.1.1. Concentration Ratio (CR)
    • 17.1.2. Herfindahl Hirschman Index (HHI)
  • 17.2. Recent Developments & Impact Analysis, 2025
  • 17.3. Product Portfolio Analysis, 2025
  • 17.4. Benchmarking Analysis, 2025
  • 17.5. Allscripts Healthcare Solutions, Inc.
  • 17.6. Cerner Corporation
  • 17.7. Conversa Health, Inc.
  • 17.8. Epic Systems Corporation
  • 17.9. GetWellNetwork, Inc.
  • 17.10. Koninklijke Philips N.V.
  • 17.11. McKesson Corporation
  • 17.12. Medisafe, Inc.
  • 17.13. NextGen Healthcare, Inc.
  • 17.14. Welltok, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 12. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CONSULTING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IMPLEMENTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUPPORT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPOINTMENT MANAGEMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MEDICATION REMINDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY TELEHEALTH, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PUBLIC CLOUD, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CUSTOMIZED DEPLOYMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DIRECT DEPLOYMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CHRONIC PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GENERAL PATIENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GOVERNMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PRIVATE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ANDROID, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY IOS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENT PORTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDER PORTAL, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 104. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 105. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 106. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 107. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 108. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 109. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 110. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 111. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 112. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 113. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 114. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 115. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 116. AMERICAS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 117. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 119. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 120. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 121. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 122. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 123. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 124. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 125. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 126. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 127. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 128. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 129. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 130. NORTH AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 131. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 132. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 133. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 134. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 135. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 136. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 137. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 138. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 139. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 140. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 141. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 142. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 143. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 144. LATIN AMERICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 145. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 146. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 147. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 148. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 149. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 150. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 151. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 152. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 153. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 154. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 159. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 161. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 162. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 163. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 164. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 165. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 166. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 173. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 175. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 176. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 177. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 178. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 179. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 180. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 187. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 188. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 189. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 190. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 191. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 192. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 193. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 194. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 201. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 202. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 203. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 204. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 205. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 206. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 207. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 208. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 209. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 210. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 211. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 212. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 213. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 214. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 225. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 230. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 231. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 232. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 233. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 234. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 235. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 236. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 237. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 238. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 239. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 240. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 241. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 242. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 243. GCC PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 252. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 253. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 254. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 255. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 256. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 257. EUROPEAN UNION PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 266. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 267. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 268. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 269. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 270. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 271. BRICS PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 272. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 274. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 275. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 276. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 277. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 278. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 279. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 280. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 281. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 282. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 283. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 284. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 285. G7 PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 286. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 288. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 289. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 290. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 291. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 292. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 293. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 294. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 295. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 296. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 297. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 298. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 299. NATO PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 300. GLOBAL PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY ON PREMISE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 309. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PATIENTS, 2018-2032 (USD MILLION)
  • TABLE 310. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PAYERS, 2018-2032 (USD MILLION)
  • TABLE 311. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY PROVIDERS, 2018-2032 (USD MILLION)
  • TABLE 312. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 313. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY MOBILE APPS, 2018-2032 (USD MILLION)
  • TABLE 314. UNITED STATES PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY WEB PORTALS, 2018-2032 (USD MILLION)
  • TABLE 315. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 316. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY COMPONENT, 2018-2032 (USD MILLION)
  • TABLE 317. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 318. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 319. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY DELIVERY MODE, 2018-2032 (USD MILLION)
  • TABLE 320. CHINA PATIENT ENGAGEMENT SOLUTION MARKET SIZE, BY CLOUD, 2018-2032 (USD MILLION)
  • TABLE 321. CHINA PATIE